Hib-diphtheria vaccine

Drug Profile

Hib-diphtheria vaccine

Alternative Names: PRP-T/diphtheria vaccine

Latest Information Update: 15 Aug 2002

Price : $50

At a glance

  • Originator Goteborg University; National Public Health Institute (Finland)
  • Class Haemophilus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Diphtheria; Haemophilus infections

Most Recent Events

  • 02 Dec 1994 Investigation in Haemophilus infections in Sweden (SC)
  • 02 Dec 1994 Investigation in Haemophilus infections in Finland (SC)
  • 02 Dec 1994 Investigation in Diphtheria in Finland (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top